Organization
Otsuka Beijing Research Institute
10 clinical trials
Clinical trial
A Phase III, Multi-center, Randomized, Single-blind (to Evaluator), Parallel, and Positive-controlled Clinical Trial Evaluating the Efficacy and Safety of OPC-1085EL Ophthalmic Solution in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese SubjectsStatus: Recruiting, Estimated PCD: 2024-03-30
Clinical trial
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Clinical Trial to Demonstrate the Superiority of 0.3% and 1% OPA-15406 Ointment Versus Vehicle in Pediatric Subjects With Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
A Multinational, Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Demonstrate the Superiority of 1% OPA-15406 Ointment to the Vehicle in Adult Patients With Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial to Evaluate the Efficacy and Safety of Different Doses of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type (IBS-D)Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Single-center, Open-label Study Evaluating the Pharmacokinetics, and Safety of Multiple Dose Oral Brexpiprazole Tablets (1 mg) in Chinese Healthy SubjectsStatus: Completed, Estimated PCD: 2020-06-10
Clinical trial
A Phase I, Open-label, Single- and Multi-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacological Effect of OPC-61815 in Healthy Chinese Male SubjectsStatus: Completed, Estimated PCD: 2022-09-21
Clinical trial
An Open-label, Crossover, Pharmacokinetic and Efficacy Bridging Study of Oral ASTX727 Versus IV Decitabine in Chinese Subjects With Myelodysplastic SyndromesStatus: Recruiting, Estimated PCD: 2025-12-30
Clinical trial
A Multi-Center, Randomized, Double-Blind Study, Comparing With Risperidone, to Evaluate the Efficacy and Safety of Aripiprazole in the Treatment of Patients With SchizophreniaStatus: Completed
Clinical trial
A Phase II Multi-center, Randomized, Open-label Study of Ponatinib in Chinese Patients With Chronic Myeloid Leukemia Who Have Failed Prior TKIs or With T315I Mutation, or Ph+ALL Who Have Failed Prior TKIs or With T315I MutationStatus: Active (not recruiting), Estimated PCD: 2022-07-22
Clinical trial
A Single-center, Open-label Study Evaluating the Pharmacokinetics, Tolerability and Safety of Single Dose Oral Brexpiprazole Tablets in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2020-05-18